Addus HomeCare (NASDAQ:ADUS) Stock Price Expected to Rise, Oppenheimer Analyst Says

Addus HomeCare (NASDAQ:ADUS) had its price target increased by equities research analysts at Oppenheimer from $145.00 to $150.00 in a research report issued on Friday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Oppenheimer’s price objective indicates a potential upside of 14.84% from the stock’s current price.

Other analysts have also issued research reports about the company. Royal Bank of Canada restated an “outperform” rating and issued a $136.00 price objective on shares of Addus HomeCare in a research note on Thursday, November 14th. Macquarie restated an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research note on Monday, November 4th. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Friday. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a research report on Monday, December 16th. Finally, JMP Securities assumed coverage on shares of Addus HomeCare in a report on Monday, December 16th. They set an “outperform” rating and a $150.00 target price for the company. One equities research analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $134.22.

Addus HomeCare Trading Up 2.8 %

NASDAQ ADUS opened at $130.62 on Friday. The company has a market cap of $2.37 billion, a PE ratio of 29.89, a PEG ratio of 1.73 and a beta of 1.00. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.72. The stock has a 50 day moving average of $126.10 and a 200-day moving average of $127.03.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.03 earnings per share. As a group, sell-side analysts predict that Addus HomeCare will post 4.58 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares in the company, valued at $9,905,569.72. The trade was a 23.95 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,750 shares of company stock valued at $4,930,750 in the last quarter. Company insiders own 4.60% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Quarry LP acquired a new stake in shares of Addus HomeCare during the 3rd quarter worth approximately $28,000. Farther Finance Advisors LLC lifted its stake in Addus HomeCare by 9,150.0% during the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after purchasing an additional 366 shares during the last quarter. KBC Group NV boosted its holdings in shares of Addus HomeCare by 49.1% in the 4th quarter. KBC Group NV now owns 814 shares of the company’s stock valued at $102,000 after purchasing an additional 268 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after purchasing an additional 191 shares during the last quarter. Finally, Assetmark Inc. raised its holdings in shares of Addus HomeCare by 11.5% during the 3rd quarter. Assetmark Inc. now owns 1,169 shares of the company’s stock worth $156,000 after buying an additional 121 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors and hedge funds.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.